Cancer and Leukemia Group B [clinicaltrials_resource:cc0ee1aa94fedadbdc9ff644e7a6cf0d]
Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer [clinicaltrials:NCT00002852]Edrecolomab in Treating Patients With Stage II Colon Cancer [clinicaltrials:NCT00002968]Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid Leukemia [clinicaltrials:NCT00003190]Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic [clinicaltrials:NCT00003440]Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia [clinicaltrials:NCT00003620]Combination Chemotherapy in Treating Patients With Stage III Colon Cancer [clinicaltrials:NCT00003835]Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia [clinicaltrials:NCT00003934]Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothelium [clinicaltrials:NCT00004856]Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer That Overexpresses HER2 [clinicaltrials:NCT00004883]506U78 in Treating Patients With Lymphoma [clinicaltrials:NCT00005080]Vaccine Plus Interleukin-2 in Treating Patients With Advanced Melanoma [clinicaltrials:NCT00005949]Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum [clinicaltrials:NCT00006094]Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia [clinicaltrials:NCT00006363]Carboxyamidotriazole in Treating Patients With Metastatic Kidney Cancer [clinicaltrials:NCT00006486]Arsenic Trioxide in Treating Patients With Urothelial Cancer [clinicaltrials:NCT00009867]Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate Cancer [clinicaltrials:NCT00016107]Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer [clinicaltrials:NCT00016276]Gefitinib in Treating Patients With Malignant Mesothelioma [clinicaltrials:NCT00025207]Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma [clinicaltrials:NCT00026143]Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction [clinicaltrials:NCT00030498]Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer [clinicaltrials:NCT00040794]Gefitinib Plus Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Bladder Cancer [clinicaltrials:NCT00041106]Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer [clinicaltrials:NCT00042952]Carboplatin and Etoposide With or Without Oblimersen Sodium in Treating Patients With Extensive Stage Small Cell Lung Cancer [clinicaltrials:NCT00042978]Oblimersen and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00049192]Tipifarnib in Treating Patients With Metastatic Malignant Melanoma [clinicaltrials:NCT00060125]clinicaltrials:NCT00061945Temozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to Melanoma [clinicaltrials:NCT00072163]Bortezomib in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma [clinicaltrials:NCT00082966]Daunorubicin Hydrochloride, Cytarabine and Oblimersen Sodium in Treating Patients With Previously Untreated Acute Myeloid Leukemia [clinicaltrials:NCT00085124]Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer [clinicaltrials:NCT00088894]clinicaltrials:NCT00098670Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma. [clinicaltrials:NCT00107432]Cisplatin, Irinotecan, and Bevacizumab, in Treating Patients With Small Cell Lung Cancer [clinicaltrials:NCT00118235]Rituximab and Oblimersen in Treating Patients With Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma [clinicaltrials:NCT00301795]clinicaltrials:NCT00337194Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine [clinicaltrials:NCT00397787]clinicaltrials:NCT00470054Biomarkers in Blood and Bone Marrow Samples From Patients With Acute Lymphoblastic Leukemia [clinicaltrials:NCT01284010]
location [clinicaltrials_vocabulary:location]
Cancer and Leukemia Group B [clinicaltrials_resource:cc0ee1aa94fedadbdc9ff644e7a6cf0d]
Bio2RDF identifier
cc0ee1aa94fedadbdc9ff644e7a6cf0d
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:cc0ee1aa94fedadbdc9ff644e7a6cf0d
address [clinicaltrials_vocabulary:address]
identifier
clinicaltrials_resource:cc0ee1aa94fedadbdc9ff644e7a6cf0d
title
Cancer and Leukemia Group B
@en
type
label
Cancer and Leukemia Group B [clinicaltrials_resource:cc0ee1aa94fedadbdc9ff644e7a6cf0d]
@en